alpha-Tocopheryl_NN
succinate_NN
inhibits_VBZ
monocytic_JJ
cell_NN
adhesion_NN
to_TO
endothelial_JJ
cells_NNS
by_IN
suppressing_VBG
NF-kappa_NN
B_NN
mobilization_NN
._.

The_DT
adherence_NN
of_IN
monocytes_NNS
to_TO
activated_VBN
endothelium_NN
is_VBZ
an_DT
early_JJ
event_NN
in_IN
atherogenesis_NN
._.

Because_IN
antioxidants_NNS
have_VBP
been_VBN
considered_VBN
to_TO
be_VB
of_IN
antiatherosclerotic_JJ
potential_NN
,_,
we_PRP
investigated_VBD
the_DT
effects_NNS
of_IN
alpha-tocopherol_NN
-LRB-_-LRB-
TCP_NN
-RRB-_-RRB-
and_CC
its_PRP$
acetate_NN
and_CC
succinate_NN
esters_NNS
on_IN
monocyte_NN
adhesion_NN
to_TO
cytokine-stimulated_JJ
human_JJ
umbilical_JJ
vein_NN
endothelial_JJ
cells_NNS
-LRB-_-LRB-
HUVEC_NN
-RRB-_-RRB-
._.

Endothelial_JJ
cells_NNS
were_VBD
treated_VBN
with_IN
TCP_NN
,_,
alpha-tocopherol_NN
acetate_NN
-LRB-_-LRB-
TCP_NN
acetate_NN
-RRB-_-RRB-
,_,
or_CC
alpha-tocopheryl_NN
succinate_NN
-LRB-_-LRB-
TCP_NN
succinate_NN
-RRB-_-RRB-
before_IN
stimulation_NN
with_IN
tumor_NN
necrosis_NN
factor-alpha_NN
-LRB-_-LRB-
TNF-alpha_NN
;_:
10_CD
U\/ml_NN
,_,
6_CD
h_NN
-RRB-_-RRB-
or_CC
interleukin-1_NN
beta_NN
-LRB-_-LRB-
IL-1_NN
beta_NN
;_:
10_CD
U\/ml_NN
,_,
6_CD
h_NN
-RRB-_-RRB-
._.

Cytokine-stimulated_JJ
cell_NN
surface_NN
expression_NN
of_IN
vascular_JJ
cell_NN
adhesion_NN
molecule-1_NN
-LRB-_-LRB-
VCAM-1_NN
,_,
CD106_NN
-RRB-_-RRB-
and_CC
E-selectin_NN
-LRB-_-LRB-
ELAM-1_NN
,_,
CD62E_NN
-RRB-_-RRB-
,_,
but_CC
not_RB
of_IN
intercellular_JJ
adhesion_NN
molecule-1_NN
-LRB-_-LRB-
ICAM-1_NN
,_,
CD54_NN
-RRB-_-RRB-
,_,
was_VBD
time_NN
-_:
and_CC
dose_NN
-_:
dependently_RB
inhibited_VBN
by_IN
TCP_NN
succinate_NN
but_CC
not_RB
by_IN
TCP_NN
or_CC
TCP_NN
acetate_NN
._.

TCP_NN
succinate_NN
-LRB-_-LRB-
200_CD
microM_NN
,_,
24_CD
h_NN
-RRB-_-RRB-
reduced_VBD
TNF-induced_JJ
VCAM-1_NN
and_CC
E-selectin_NN
expression_NN
from_IN
a_DT
specific_JJ
mean_NN
fluorescence_NN
intensity_NN
of_IN
151_CD
+_NN
\/_:
-_:
28_CD
to_TO
12_CD
+_CC
\/_JJ
-_:
4_CD
channels_NNS
and_CC
from_IN
225_CD
+_JJ
\/_:
-_:
38_CD
to_TO
79_CD
+_CC
\/_JJ
-_:
21_CD
channels_NNS
,_,
respectively_RB
._.

Succinate_NN
alone_RB
had_VBD
no_DT
effect_NN
._.

Decreased_VBN
adhesion_NN
molecule_NN
expression_NN
was_VBD
associated_VBN
with_IN
a_DT
reduction_NN
of_IN
monocytic_JJ
cell_NN
adhesion_NN
._.

TCP_NN
succinate_NN
-LRB-_-LRB-
20_CD
microM_NN
,_,
72_CD
h_NN
-RRB-_-RRB-
,_,
but_CC
not_RB
TCP_NN
-LRB-_-LRB-
200_CD
microM_NN
,_,
72_CD
h_NN
-RRB-_-RRB-
,_,
reduced_VBD
U-937_NN
cell_NN
adhesion_NN
to_TO
TNF-alpha-stimulated_JJ
-LRB-_-LRB-
10_CD
U\/ml_NN
,_,
6_CD
h_NN
-RRB-_-RRB-
HUVEC_NNS
by_IN
30_CD
%_NN
-LRB-_-LRB-
P_NN
&lt;_JJR
0.025_CD
-RRB-_-RRB-
and_CC
to_TO
IL-1_NN
beta-stimulated_JJ
HUVEC_NNS
by_IN
56_CD
%_NN
-LRB-_-LRB-
P_NN
&lt;_JJR
0.010_CD
-RRB-_-RRB-
._.

Electrophoretic_JJ
mobility-shift_JJ
assays_NNS
of_IN
HUVEC_NN
nuclear_JJ
proteins_NNS
revealed_VBD
a_DT
decrease_NN
in_IN
TNF-alpha-stimulated_JJ
nuclear_JJ
factor-kappa_NN
B_NN
-LRB-_-LRB-
NF-kappa_NN
B_NN
-RRB-_-RRB-
activation_NN
after_IN
pretreatment_NN
of_IN
HUVEC_NN
with_IN
TCP_NN
succinate_NN
but_CC
not_RB
with_IN
TCP_NN
,_,
TCP_NN
acetate_NN
,_,
or_CC
succinate_NN
alone_RB
._.

In_IN
conclusion_NN
,_,
we_PRP
demonstrate_VBP
that_IN
the_DT
vitamin_NN
E_NN
derivative_NN
TCP_NN
succinate_NN
prevents_VBZ
monocytic_JJ
cell_NN
adhesion_NN
to_TO
cytokine-stimulated_JJ
endothelial_JJ
cells_NNS
by_IN
inhibiting_VBG
the_DT
activation_NN
of_IN
NF-kappa_NN
B_NN
,_,
further_RB
emphasizing_VBG
the_DT
antiatherosclerotic_JJ
potential_NN
of_IN
lipid_NN
soluble_JJ
antioxidants_NNS
._.

